Sign In
Buy LLY
$1,083.23
+18.39 (+1.73%)
At Close: Jun 03, 2026
Linden Lake Labs Applauds Acquisition of Portfolio Company CrossBridge Bio by Eli Lilly and Company
09:00am, Tuesday, 14'th Apr 2026
ROCKVILLE, Md.--(BUSINESS WIRE)--Linden Lake Labs (“L3”), an early-stage life sciences platform committed to advancing innovative therapies, today announced that its portfolio company, CrossBridge
CrossBridge Bio Enters an Agreement to be Acquired by Eli Lilly to Advance Next-Generation Dual-Payload Antibody-Drug Conjugates
08:00am, Tuesday, 14'th Apr 2026
HOUSTON--(BUSINESS WIRE)--CrossBridge Bio, Inc., a pre-clinical biotechnology company pioneering the development of next-generation dual-payload antibody-drug conjugates (ADCs) today announced a defin
Eli Lilly and Company $LLY Stock Position Raised by Apollon Wealth Management LLC
04:48am, Tuesday, 14'th Apr 2026
Apollon Wealth Management LLC lifted its holdings in Eli Lilly and Company (NYSE: LLY) by 1.6% in the undefined quarter, according to the company in its most recent disclosure with the Securities and
Eli Lilly Advances Leukemia Drug in Late-Stage Trial
01:12pm, Monday, 13'th Apr 2026
Eli Lilly and Company (LLY, Financials) announced that its leukemia drug Jaypirca did well in a Phase 3 clinical trial. This is a good thing for the company's c
BRUIN CLL-322 is the first Phase 3 readout in CLL to utilize and outperform a venetoclax-containing control arm This trial predominantly enrolled a patient population previously treated with covalent
Eli Lilly Isn't Replacing Zepbound -- It's Building an Obesity Empire
10:30am, Saturday, 11'th Apr 2026
Eli Lilly's newer weight-loss medicines will help cement its dominance in the market. The company could ride this tailwind through the medium term and deliver strong returns.
Trump policies, China's biotech boom are ending Europe's pharma powerhouse era
01:54am, Saturday, 11'th Apr 2026
Once the go-to location for global drugmakers, Europe is losing market share to aggressive U.S. trade policies and China's growth as a biotech hub. Europe's share of global R&D has been cut in half ov
Eli Lilly vs. Novo Nordisk: The Obesity Drug Race Has a New Leader
12:09pm, Friday, 10'th Apr 2026
Eli Lilly and Company (NYSE:LLY | LLY Price Prediction) and Novo Nordisk A/S (NYSE:NVO) reported quarterly results in early February, and the gap between them has widened significantly.
Who Benefits From Amazon Pharmacy Stocking Eli Lilly's New Weight Loss Pill
08:25am, Friday, 10'th Apr 2026
Amazon (NASDAQ: AMZN | AMZN Price Prediction) just made a quiet move that could reshape how Americans access weight-loss drugs.
Apella Capital LLC Acquires 1,083 Shares of Eli Lilly and Company $LLY
04:54am, Friday, 10'th Apr 2026
Apella Capital LLC boosted its holdings in shares of Eli Lilly and Company (NYSE: LLY) by 51.8% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities a
Eli Lilly market share drops, Novo Nordisk holds firm as generic weight-loss drugs flood India
02:38am, Friday, 10'th Apr 2026
Eli Lilly's market share in India's weight‑loss drug market fell to 56% in March from 61% in February. Novo Nordisk's market share remained steady at 25%.
Rep. Gilbert Ray Cisneros, Jr. Sells Eli Lilly and Company (NYSE:LLY) Shares
02:03am, Friday, 10'th Apr 2026
Representative Gilbert Ray Cisneros, Jr. (Democratic-California) recently sold shares of Eli Lilly and Company (NYSE: LLY). In a filing disclosed on April 07th, the Representative disclosed that they
Eli Lilly's Weight-Loss Pill Hits the Shelves. It's a Turning Point for the Stock.
01:27pm, Thursday, 09'th Apr 2026
The pharmaceutical's Foundayo drug takes on oral Wegovy, the popular treatment from Novo Nordisk.
CRWV, CVX, LLY, TSLA Lead Thursday Watchlist
12:25pm, Thursday, 09'th Apr 2026
CoreWeave (CRWV), Chevron (CVX), Eli Lilly (LLY), and Tesla (TSLA) are all in focus Thursday, each moving on very different headlines as markets open on a cauti
Eli Lilly Stock in Focus -- New Pill Launch Challenges Novo Nordisk
12:23pm, Thursday, 09'th Apr 2026
Eli Lilly (LLY) said its newly approved weight-loss pill Foundayo will be sold at U.S. retail pharmacies starting Thursday, giving Eli Lilly stock a fresh catal
